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Abstract 
Objective 
To evaluate contemporary international trends in the implementation of minimally invasive 
adrenalectomy and to assess contemporary outcomes of different minimally invasive techniques 
performed at urologic centers worldwide. 
Methods 
A retrospective multinational multicenter study of patients who underwent minimally invasive 
adrenalectomy from 2008 to 2013 at 14 urology institutions worldwide was included in the analysis. 
Cases were categorized based on the minimally invasive adrenalectomy technique: conventional 
laparoscopy (CL), robot-assisted laparoscopy (RAL), laparoendoscopic single-site surgery (LESS), 
and mini-laparoscopy (ML). The rates of the four treatment modalities were determined according 
to the year of surgery, and a regression analysis was performed for trends in all surgical modalities. 
Results 
Overall, a total of 737 adrenalectomies were performed across participating institutions and 
included in this analysis: 337 CL (46 % of cases), 57 ML (8 %), 263 LESS (36 %), and 80 RA 
(11 %). Overall, 204 (28 %) operations were performed with a retroperitoneal approach. The overall 
number of adrenalectomies increased from 2008 to 2013 (p = 0.05). A transperitoneal approach was 
preferred in all but the ML group (p < 0.001). European centers mostly adopted CL and ML 
techniques, whereas those from Asia and South America reported the highest rate in LESS 
procedures, and RAL was adopted to larger extent in the USA. LESS had the fastest increase in 
utilization at 6 %/year. The rate of RAL procedures increased at slower rates (2.2 %/year), similar 
to ML (1.7 %/year). Limitations of this study are the retrospective design and the lack of a cost 
analysis. 
Conclusions 
Several minimally invasive surgical techniques for the management of adrenal masses are 
successfully implemented in urology institutions worldwide. CL and LESS seem to represent the 
most commonly adopted techniques, whereas ML and RAL are growing at a slower rate. All the 
MIS techniques can be safely and effectively performed for a variety of adrenal disease. 
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Introduction 
Since the report of the first series in the early nineties [1], conventional laparoscopy (CL) for the 
surgical management of adrenal lesions has been safely implemented [2], given potential 
advantages over open surgery [3]. In addition, over the past 10 years, different minimally invasive 
techniques have been explored, including mini-laparoscopy (ML) [4], robot-assisted laparoscopy 
(RAL) [5], and laparoendoscopic single-site surgery (LESS) [6]. 
Few studies have explored the trends in the use of laparoscopic adrenalectomy at national level [7–
9], whereas more specific data regarding the adoption of this and other minimally invasive 
techniques at multinational level are lacking. Moreover, most of the trend analysis in this field has 
been reported in general (endocrine) surgery literature [3, 7, 10]. In this scenario, it remains to be 
determined to what extent the introduction of all these novel techniques has impacted the surgical 
management of adrenal gland and what have been the outcomes following the implementation of 
these techniques in urologic institutions. 
The aim of this study was to evaluate the contemporary international trends and outcomes in the 
minimally invasive surgical management of adrenal masses among urology centers worldwide. 
Patients and methods 
Study design 
This was a retrospective multicenter study including data from 14 urology centers worldwide: 
Europe (Italy, Greece, Spain, UK, and Germany), Asia (Korea, Japan, and China), South America 
(Brazil), and USA (Ohio and California). Consecutive cases of minimally invasive adrenalectomy 
(any technique) performed between 2008 and 2013 were collected. Each group performed the 
procedures according to its own surgical indication, protocol, and technique. Raw data without any 
identifier were retrospectively collected and gathered in a standardized datasheet, which was 
specifically built for study purpose. Institutional review board approval or waiver was obtained at 
each participating center. 
Parameters 
Demographic data included age, gender, race, body mass index (BMI), history of previous 
abdominal surgery, and American Society of Anesthesiologists (ASA) score. Information related to 
the adrenal mass was also collected, namely size, side (left or right), pathology (malignant or 
benign), and presentation (incidentaloma or not). Procedures were categorized according to the 
minimally invasive technique: CL, LESS, ML, and RAL. In addition, the approach was also 
recorded (transperitoneal vs. retroperitoneal). The following surgical parameters were analyzed: 
operative time, estimated blood loss, intraoperative and postoperative complications, conversions, 
transfusions, length of stay, and readmission rate. 
Statistical analysis 
Continuous parametric variables were reported as the mean ± standard deviation (SD), while 
nonparametric variables were reported as the median and interquartile range (IQR). Descriptive 
analysis was performed using Pearson’s Chi-squared test for categorical data, Student’s t test for 
continuous data, and Mann–Whitney test for nonnormally distributed continuous data. The rates of 
the four treatment modalities were determined according to the year of surgery, and a regression 
analysis was performed for trends in all surgical modalities. Analyses were conducted with SAS 
software, version 9.1 (SAS Institute, Inc. Cary, NC, USA). 
Results 
Study population 
Seven hundred and thirty-seven patients underwent minimally invasive adrenalectomy at 
participating centers during the study period. Patients’ characteristics are summarized in Table 1. 
Patients undergoing LESS were younger (men age 48 ± 12.4 years) compared to other groups 
(p < 0.001). A higher BMI was observed in patients in the RAL group (mean BMI 30.3 kg/m
2
) 
which was significantly higher compared to other techniques (p < 0.001). In addition those 
undergoing RAL presented a higher ASA score (p < 0.001) as well as a higher incidence of 
previous abdominal surgery (38.7 %, p = 0.007). On the other hand, RAL group presented a higher 
proportion of incidental diagnosis of adrenal mass (55 %, p = 0.02) and also a smaller size (median 
2.7 cm, IQR 1.6–4.5; p = 0.003). LESS was used mostly for benign indications compared to other 
techniques (89.8 % of cases, p < 0.001). 
Table 1 
Main demographics 
  ML (n = 57) LESS (n = 263) RAL (n = 80) CL (n = 337) p value 
Patient characteristics 
Age, mean (SD) 54.24 (11.36) 48.09 (12.38) 55.44 (13.24) 53.19 (13.77) <0.001 
Gender         0.338 
 Male 28 (49) 122 (47) 46 (58) 158 (47)   
 Female 29 (51) 141 (53) 35 (43) 179 (53)   
Race         <0.001 
 Caucasian 57 (100) 45 (17.1) 70 (87.5) 186 (55.5)   
 Asian 0 217 (82.5) 2 (2.5) 138 (41.2)   
 African American 0 0 6 (7.5) 6 (1.8)   
BMI, kg/m
2
, mean (SD) 26.09 (2.88) 24.69 (30.24) 30.28 (7.55) 25.99 (4.74) <0.001 
ASA, n (%)         <0.001 
 1 5 (8.8) 64 (24.3) 8 (10) 44 (13.1)   
 2 35 (61.4) 143 (54.4) 21 (26.3) 208 (62.1)   
 3 15 (26.3) 33 (12.5) 45 (56.3) 77 (23.0)   
 4 0 2 (0.8) 6 (7.5) 6 (1.8)   
Prior abdominal surgery, n (%) 12 (21) 57 (21.7) 31 (38.7) 99 (29.3) 0.007 
Adrenal mass characteristics 
Incidentaloma, n (%) 25 (43.9) 95 (36.1) 44 (55) 141(42.1) 0.02 
Size, cm, median (IQR) 3 (2.5–3.6) 3 (2–4.15) 2.7 (1.6–4.5) 3.5 (2.6–5) 0.003 
  ML (n = 57) LESS (n = 263) RAL (n = 80) CL (n = 337) p value 
Pathology         <0.001 
 Malignant 10 (17.5) 9 (3.4) 18 (22.5) 88 (26.3)   
 Benign 45 (78.9) 236 (89.8) 58 (72.5) 217 (64.8)   
Side         0.067 
 Right 29 (50.9) 95 (36.1) 33 (41.3) 158 (47.5)   
 Left 26 (45.6) 149 (56.7) 42 (52.5) 142 (42.4)   
 Bilateral 0 1 (0.4) 1 (1.3) 5 (1.5)   
Surgical outcomes 
The surgical outcomes are summarized in Table 2. A transperitoneal approach was preferred in all 
but the ML group (p < 0.001). Overall, 204 (28 %) operations were performed with a 
retroperitoneal approach: 122 (36 %) CL and 82 (31 %) LESS. The median operative time was 
higher for RAL (150 min, 120–180), compared to CL (120 min, 85–150), LESS (117 min, IQR 90–
150), and ML who had the shorter time (90 min, 80–120) (p < 0.001). No significant difference was 
found in terms of intraoperative transfusions and complications, as well as conversions. On the 
other hand, postoperative complication rate was higher for RAL group (21.3 %) compared to ML 
(12.3 %), LESS (4.2 %), and CL (8.7 %) (p = 0.001). Length of hospital stay was shorter for ML 
(median 3, 3–3) and RAL (2, 2–4) (p < 0.001). 
Table 2 
Surgical outcomes 
  
ML 
(n = 57) 
LESS 
(n = 263) 
RAL (n = 80) 
CL 
(n = 337) 
p value 
Transperitoneal approach, n 
(%) 
8 (14.0) 169 (64.3) 75 (93.7) 220 (65.3) < 0.001 
OR time, Median (IQR) 90 (80–120) 117 (90–150) 
150 (120–
180) 
120 (85–150) <0.001 
EBL, median (IQR) 50 (50–100) 50 (0–100) 50 (50–150) 50 (40–90) 0.002 
Transfusion intraop, N (%) 1 (1.8) 2 (0.8) 4 (5) 8 (2.4) 0.117 
Intraop complications, N (%) 6 (10.5) 14 (5.3) 5 (6.3) 11 (3.3) 0.104 
Conversion, N (%) 0 6 (2.3) 2 (2.5) 10 (3) 0.627 
Transfusion post op, N (%) 4 (7) 0 4 (5) 11 (3.3) <0.001 
Post op complication, N (%) 
 Overall 9 (15.8) 11 (4.2) 17 (21.3) 29 (8.7) 0.001 
 Minor (Clavien 1–2) 9 (15.8) 9 (3.4) 15 (18.8) 26 (7.8) <0.001 
 Major (Clavien 3–4) 0 2 (0.8) 2 (2.5) 3 (0.9) 0.565 
LOS, median (IQR) 3 (3–3) 5 (4–7) 2 (2–4) 6 (4–8) < 0.001 
Trends in surgical techniques 
The regional distribution of the different minimally invasive adrenalectomy techniques is illustrated 
in Fig. 1. European centers mostly adopted CL and ML techniques, whereas centers from Asia and 
South America reported the highest rate LESS procedures, whereas RAL was adopted to larger 
extent in the USA. 
 
Fig. 1 
Number of adrenalectomy cases during study period by regional contribution and technique (CL 
conventional laparoscopy, RA robot-assisted laparoscopy, LESS laparoendoscopic single-site 
surgery, ML mini-laparoscopy) 
The overall numbers of adrenalectomies significantly increased from 2008 to 2013 (p = 0.05). 
Numbers of procedures according to the adopted technique are shown in Fig. 2. The overall 
utilization of CL and LESS has been steadily increasing and the fastest growing, as shown in Fig. 3. 
However, the proportion of CL adrenalectomies along the study period decreased from 100 to 39 %. 
Other MIS techniques showed an increase in utilization: LESS, RAL, and ML had increased to 42, 
13, and 10 %, respectively. From 2008 to 2013, LESS had the fastest increase in utilization at 
6 %/year. The rate of RAL procedures started to increase from 2009, but at slower rates 
(2.2 %/year), similar to ML (1.7 %/year). 
 
Fig. 2 
Trends in the number of adrenalectomies by MIS technique during study period (CL conventional 
laparoscopy, RA robot-assisted laparoscopy, LESS laparoendoscopic single-site surgery, ML mini-
laparoscopy) 
 
Fig. 3 
Trends in the rate of each MIS technique during the study period (CL conventional laparoscopy, RA 
robot-assisted laparoscopy, LESS laparoendoscopic single-site surgery, ML mini-laparoscopy) 
Discussion 
The present large series allows evaluating contemporary trends and outcomes in minimally invasive 
management of adrenal masses at urology centers in different continents. To our knowledge, no 
other multiinstitutional multinational series including not only CL but also other MIS techniques 
has been reported to date. As such, this represents a unique “real-life” dataset allowing several 
arguments. 
Overall, present study findings suggest an overall increase in the utilization of MIS techniques for 
adrenal surgery, which is in line with available population-based data analyses. Monn et al. recently 
analyzed the national trends for adrenalectomy in the USA during the time period 2002–2011 using 
the Nationwide Inpatient Sample [2]. A MIS approach was used in 20 % of the 58,948 
adrenalectomies included in the analysis. There was a 4 % increase in MIS throughout the study 
period (p < 0.001). However, adrenalectomy by urologists showed a 15 % annual decrease 
(p < 0.001). Using the same database (years 1999–2005), Park et al. [10] assessed the effect of 
surgeon volume and specialty on the outcomes of adrenalectomy procedure. After adjusting for 
patient’s and provider’s characteristics, surgeon volume, not specialty, was an independent 
predictor of complications (OR 1.5, p < 0.002). More recently, Simhan et al. [11] analyzed 1996–
2009 hospital discharge data from New York, New Jersey, and Pennsylvania of 8381 
adrenalectomy cases. For each successive year, the odds of having surgery performed at a very low 
volume hospital decreased by 13 %. When controlling for year treated, patients were less likely to 
die in the hospital if treated at a very high-volume hospital (OR 0.38, 95 % CI 0.19–0.75). One of 
the very few multiinstitutional laparoscopic adrenalectomy series from urological centers has been 
reported. Greco et al. [9] analyzed 363 cases performed at 23 German hospitals. They concluded 
that LA performed by urologists experienced in laparoscopy can be safe for the removal of benign 
and malignant adrenal masses. 
Over the past decade, besides the adoption of CL, other MIS options have been explored by 
urologic surgeons worldwide. Utilization of RAL has exponentially grown in urology following the 
driven by its large-scale use for radical prostatectomy [12]. Consequently, other urology indications 
for robotic surgery have also grown significantly [13]. Not surprisingly, we found robotic adrenal 
surgery to have increased to a larger extent in the USA, where diffusion of robotic platforms has 
been more significant compared to other regions of the globe. RAL technique has been certainly 
standardized [5], and the procedure can be performed safely and effectively with potential 
advantages of a shorter hospital stay, less blood loss, and lower occurrence of postoperative 
complications [14]. In our study, a higher BMI was observed in patients undergoing RAL group 
(mean BMI 30.3 kg/m
2
) which was significantly higher compared to other techniques (p < 0.001). 
This might be simply explained by the fact that RAL was mainly performed in US Centers. 
Recently published Society of Gastrointestinal and Endoscopic Surgeons (SAGES) guidelines 
support the use of robot-assisted laparoscopy in patients with high BMI, as well those with larger 
tumors [15]. In our study, however, RAL group presented a higher proportion of incidental 
diagnosis of adrenal mass (55 %) and also a smaller median size (2.7 cm). The upper size for a 
laparoscopic adrenalectomy for an experienced minimally invasive surgeon is usually considered to 
be as high as 10–14 cm, and >6–7 cm has been considered as the upper limit in earlier stages of 
experience [16]. Therefore, it can be speculated that careful selection criteria were adopted, not only 
for RAL but also for other MIS techniques in our study. 
LESS adrenal surgery has been embraced by several groups for a number of different indications 
and by using a variety of approaches [17]. A recent meta-analysis suggests that LESS 
adrenalectomy seems to be a safe and feasible alternative to its conventional laparoscopic 
counterpart with decreased postoperative pain, but a longer operative time [18]. This is likely to be 
related to the technical challenges of the procedure, which likely represent a barrier to its 
implementation [19]. From 2008 to 2013, LESS had the fastest increase in utilization at 6 %/year 
among the techniques in our study. Not surprisingly, LESS was more used for benign indications 
compared to other techniques (89.8 % of cases, p < 0.001), suggesting that surgeons approached 
this novel technique with some caution. To note, centers from Asia and South America reported the 
highest rate of LESS procedures, which is not unexpected, given the several reports coming from 
those regions of the world over the past few years [18]. Whether adoption of LESS in the respective 
countries is driven by patient demand and focus on cosmetic outcome is speculative remains to be 
determined. To this regard, it must be pointed out that safety and efficacy remain the key factors in 
the decision-making process of patients undergoing minimally invasive surgery [19]. The left side 
was preferred for LESS cases, and this could be explained by the fact this side might be easier with 
this approach, as recently suggested by Hora et al. [20]. 
Recently, ML has been rediscovered in an attempt to reduce the trauma on abdominal wall derived 
from standard laparoscopic access, improving cosmetic outcome and recovery. ML can be regarded 
as a viable option when looking for a virtually “scarless” surgery. Its rediscovery has been fueled by 
the availability of more reliable instrumentation and by the fact that ML allows minimal abdominal 
scar in the meanwhile preserving the key principle of triangulation [21]. A recent large 
multiinstitutional European series showed that a broad range of common procedures can be safely 
and effectively performed with contemporary ML techniques [22]. Interestingly, ML group was the 
only one in our study where most of the cases (86 %) were performed by using a 
retroperitoneoscopic approach. It remains to be determined whether this can partially account for 
the shorter operative time (median 90 min) and length of hospital stay (median 3 days) observed in 
the ML group compared to others. A recent meta-analysis suggested that a retroperitoneal approach 
is associated with shorter operative time (WMD: −13.10 min), less intraoperative blood loss 
(WMD: −40.6 ml), and shorter duration of hospital stay (WMD: −1.25 days) [23]. Certainly, the 
best approach for adrenalectomy procedure remains a debated issue [24]. 
Main limitations of this study need to be acknowledged: first, its retrospective design, which might 
account for inaccuracies in data reporting, and which necessarily limited the analysis to the 
parameters that were of sufficient quality, and second, the centers who agreed to participate are 
high-volume teaching institutions. Therefore, study findings should be applicable with caution in 
other hospital settings. Also, a cost analysis was outside the scope of this study, and this issue 
certainly needs further investigation. As the present study includes different health systems, it 
would be prohibitive to have a cost comparison, as significant parameters, for example, length of 
stay, are largely influenced by nonclinical factors (reimbursement systems). Despite the lack of 
specific cost analysis studies for adrenalectomy, potential increased costs associated with robotic 
surgery represent an issue that is currently being debated [25]. All these limitations being said, this 
study represents, to our knowledge, the largest contemporary urologic series of minimally invasive 
adrenalectomy procedures. Ideally, prospective comparative studies are awaited as they would 
represent the best way to compare these different techniques, and to ultimately determine their role 
in current adrenal surgery armamentarium. 
In conclusion, several MIS techniques for the management of adrenal masses are successfully 
implemented in urology institutions worldwide. Therefore, MIS can safely and effectively replace 
open adrenalectomy for variety of indications wherever expertise in these techniques is available. 
CL still represents the most widely used MIS technique worldwide. Among the others, LESS has 
been the one most commonly adopted, whereas ML and RAL have been growing at a slower rate. 
Further investigation is necessary to understand the driving forces behind these trends. Well-
designed prospective comparative studies are ideally needed to better define the role of each of 
these surgical options in the armamentarium of urologic surgeons managing adrenal diseases. 
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